Persistent LCMV Infection Is Controlled by Blockade of Type I Interferon Signaling

John R. Teijaro(Scripps Research Institute), Cherie Ng(Scripps Research Institute), Andrew M. Lee(Scripps Research Institute), Brian M. Sullivan(Scripps Research Institute), Kathleen C. F. Sheehan(Washington University in St. Louis), Megan J. Welch(Scripps Research Institute), Robert D. Schreiber(Washington University in St. Louis), Juan Carlos de la Torre(Scripps Research Institute), Michael B. A. Oldstone(Scripps Research Institute)
Science
April 11, 2013
Cited by 753

Abstract

During persistent viral infections, chronic immune activation, negative immune regulator expression, an elevated interferon signature, and lymphoid tissue destruction correlate with disease progression. We demonstrated that blockade of type I interferon (IFN-I) signaling using an IFN-I receptor neutralizing antibody reduced immune system activation, decreased expression of negative immune regulatory molecules, and restored lymphoid architecture in mice persistently infected with lymphocytic choriomeningitis virus. IFN-I blockade before and after establishment of persistent virus infection resulted in enhanced virus clearance and was CD4 T cell-dependent. Hence, we demonstrate a direct causal link between IFN-I signaling, immune activation, negative immune regulator expression, lymphoid tissue disorganization, and virus persistence. Our results suggest that therapies targeting IFN-I may help control persistent virus infections.


Related Papers

No related papers found

Powered by citation graph analysis